Conn. Gen. Stat. § 38a-518g

Current with legislation from the 2024 Regular and Special Sessions.
Section 38a-518g - Mandatory coverage for prostate cancer screening and treatment

Each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for:

(1) Laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older; and
(2) The treatment of prostate cancer, provided such treatment is medically necessary and in accordance with guidelines established by the National Comprehensive Cancer Network, the American Cancer Society or the American Society of Clinical Oncology.

Conn. Gen. Stat. § 38a-518g

( P.A. 99-284, S. 46, 60; P.A. 11-225, S. 2.)

Amended by P.A. 11-0225, S. 2 of the the 2011 Regular Session, eff. 1/1/2012.

See Sec. 38a-492g for similar provisions re individual policies.